z-logo
open-access-imgOpen Access
Direct-acting antiviral-based triple therapy on alpha-fetoprotein level in chronic hepatitis C patients
Author(s) -
Kōji Takayama,
Norihiro Furusyo,
Eiichi Ogawa,
Hiroaki Ikezaki,
Motohiro Shimizu,
Masayuki Murata,
Jun Hayashi
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i15.4696
Subject(s) - telaprevir , ribavirin , medicine , pegylated interferon , gastroenterology , hepatitis c , alpha fetoprotein , alpha interferon , viral load , chronic hepatitis , immunology , interferon , virus , hepatocellular carcinoma
To investigate the impact of telaprevir-based triple therapy on the serum alpha-fetoprotein (AFP) level of chronic hepatitis C patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom